Bionano Genomics, Inc. Increase (Decrease) in Accounts Receivable
Bionano Genomics, Inc. (BNGO) reported Increase (Decrease) in Accounts Receivable of -$834.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $233.00K, a 65.25% increase year-over-year.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.07M.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $674.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.03M.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $448.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$4.14M, a 280.27% decline from fiscal 2023.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $2.30M, a 2.00% increase from fiscal 2022.
- Bionano Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $2.25M, a 356.59% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$834.00K 10-Q · filed 2026-08-10 | -$160.00K derived: sum of 3 quarters · filed 2026-08-10 | $871.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$1.07M 10-Q · filed 2026-05-13 | -$393.00K derived: sum of 2 quarters · filed 2026-05-13 | $638.00K derived: sum of 3 quarters · filed 2026-05-13 | $779.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.71M derived: sum of 2 quarters · filed 2026-03-23 | $1.85M derived: sum of 3 quarters · filed 2026-08-10 | $448.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.17M derived: sum of 2 quarters · filed 2026-08-10 | -$226.00K 10-Q · filed 2025-11-13 | -$359.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.26M 10-Q · filed 2026-08-10 | -$1.39M derived: sum of 3 quarters · filed 2026-08-10 | -$2.33M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$1.40M 10-Q · filed 2026-05-13 | -$1.53M derived: sum of 2 quarters · filed 2026-05-13 | -$2.47M derived: sum of 3 quarters · filed 2026-05-13 | -$4.53M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$1.07M derived: sum of 2 quarters · filed 2026-03-23 | -$3.13M derived: sum of 3 quarters · filed 2026-03-23 | -$4.14M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$942.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.00M derived: sum of 2 quarters · filed 2025-11-13 | -$4.01M 10-Q · filed 2025-11-13 | -$3.36M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.06M 10-Q · filed 2025-08-14 | -$2.41M derived: sum of 3 quarters · filed 2025-08-14 | -$1.36M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$1.00M 10-Q · filed 2025-05-14 | -$354.00K derived: sum of 2 quarters · filed 2025-05-14 | $702.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.53M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.71M derived: sum of 2 quarters · filed 2025-03-31 | $2.54M derived: sum of 3 quarters · filed 2025-03-31 | $2.30M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.89M derived: sum of 2 quarters · filed 2024-11-14 | $1.65M 10-Q · filed 2024-11-14 | $2.76M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $832.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $590.00K 10-Q · filed 2024-08-07 | $1.71M derived: sum of 3 quarters · filed 2024-08-07 | $2.87M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$242.00K 10-Q · filed 2024-05-08 | $875.00K derived: sum of 2 quarters · filed 2024-05-08 | $2.03M derived: sum of 3 quarters · filed 2024-05-08 | $1.37M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.27M derived: sum of 2 quarters · filed 2024-03-05 | $1.61M derived: sum of 3 quarters · filed 2024-03-05 | $2.25M 10-K · filed 2024-03-05 | $2.90M 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $494.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.13M 10-Q · filed 2023-11-08 | $1.17M 10-Q · filed 2022-11-03 | $1.29M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$24.00K 10-Q · filed 2023-08-09 | $133.00K derived: sum of 3 quarters · filed 2023-08-09 | $406.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $640.00K 10-Q · filed 2023-05-09 | $797.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.07M derived: sum of 3 quarters · filed 2023-05-09 | $1.92M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $430.00K derived: sum of 2 quarters · filed 2023-03-09 | $1.28M derived: sum of 3 quarters · filed 2023-03-09 | $493.00K 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.12M derived: sum of 2 quarters · filed 2022-11-03 | $336.00K 10-Q · filed 2022-11-03 | -$42.00K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $846.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $63.00K 10-Q · filed 2022-08-04 | -$315.00K derived: sum of 3 quarters · filed 2022-08-04 | -$229.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$783.00K 10-Q · filed 2022-05-05 | -$1.16M derived: sum of 2 quarters · filed 2022-05-05 | -$1.07M derived: sum of 3 quarters · filed 2022-05-05 | -$1.61M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$292.00K derived: sum of 2 quarters · filed 2022-03-01 | -$826.00K derived: sum of 3 quarters · filed 2022-03-01 | -$2.09M 10-K · filed 2022-03-01 | -$2.09M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$448.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.71M 10-Q · filed 2021-11-04 | -$820.50K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.79M 10-Q · filed 2021-08-04 | -$906.50K derived: sum of 3 quarters · filed 2021-08-04 | $110.50K derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$1.26M 10-Q · filed 2021-05-13 | -$372.50K derived: sum of 2 quarters · filed 2021-05-13 | $644.50K derived: sum of 3 quarters · filed 2021-05-13 | $1.57M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $888.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $1.91M derived: sum of 2 quarters · filed 2021-03-23 | $2.83M derived: sum of 3 quarters · filed 2021-03-23 | $2.37M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.94M derived: sum of 2 quarters · filed 2020-11-13 | $1.49M 10-Q · filed 2020-11-13 | $1.49M 10-Q · filed 2019-11-07 | $2.00M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $926.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $469.00K 10-Q · filed 2020-08-13 | $469.18K 10-Q · filed 2019-08-08 | $982.41K derived: sum of 3 quarters · filed 2020-08-13 | $1.60M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$457.00K 10-Q · filed 2020-06-18 | -$457.20K 10-Q · filed 2019-05-09 | $56.41K derived: sum of 2 quarters · filed 2020-06-18 | $671.13K derived: sum of 3 quarters · filed 2020-06-18 | $1.26M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | $513.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.13M derived: sum of 2 quarters · filed 2020-03-10 | $1.72M derived: sum of 3 quarters · filed 2020-03-10 | $900.12K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $614.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.20M derived: sum of 2 quarters · filed 2019-11-07 | $386.71K 10-Q · filed 2019-11-07 | $1.46M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $588.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$228.01K 10-Q · filed 2019-08-08 | $847.00K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | -$816.32K 10-Q · filed 2019-05-09 | $258.69K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.77M 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | $692.64K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |